| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 21 |
| 1 | LEVETIRACETAM IN SODIUM CHLORIDE | 19 |
| 2 | LEVETIRACETAM INJECTION | 19 |
| 3 | LEVETIRACETAM ORAL | 19 |
| 4 | METHOTREXATE SODIUM | 19 |
| 5 | LAMOTRIGINE | 18 |
| 6 | LORAZEPAM | 18 |
| 7 | METHOTREXATE | 18 |
| 8 | CLONAZEPAM | 17 |
| 9 | LAMOTIRIGINE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIMODIPINE | 3 | 0.0027 |
| 1 | PERAMPANEL | 16 | 0.0021 |
| 2 | ANDEXANET ALFA | 1 | 0.0014 |
| 3 | CORTISONE ACETATE | 15 | 0.0012 |
| 4 | NELARABINE | 1 | 0.0010 |
| 5 | VALPROATE SODIUM | 16 | 0.0008 |
| 6 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 7 | EDARAVONE | 1 | 0.0006 |
| 8 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 9 | DEXMEDETOMIDINE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 21 |
| 1 | Corticosteroid [EPC] | 21 |
| 2 | Anti-epileptic Agent [EPC] | 20 |
| 3 | Mood Stabilizer [EPC] | 19 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 5 | Alkylating Drug [EPC] | 16 |
| 6 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 16 |
| 7 | Recombinant Human Growth Hormone [EPC] | 13 |
| 8 | Topoisomerase Inhibitor [EPC] | 10 |
| 9 | Platinum-based Drug [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 16 | 0.0021 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 2 | Recombinant Human Growth Hormone [EPC] | 13 | 0.0006 |
| 3 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 4 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 5 | Anti-epileptic Agent [EPC] | 20 | 0.0001 |
| 6 | Mood Stabilizer [EPC] | 19 | 0.0001 |
| 7 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 9 | Anticholinergic [EPC] | 1 | 0.0001 |